Eduard Shantsila

ਸਿੱਖਿਅਤ ਹੋਏ: University of Birmingham

ਕਾਰੋਬਾਰ: ਖੋਜੀ

Series

There is nothing here

Create a new serie

Works

There is nothing here

Create a new work

Articles 183

Date

ਸਿਰਲੇਖ

ਲੇਖਕ

2020-02-10

Imaging, biomarker and invasive assessment of diffuse left ventricular myocardial fibrosis in atrial fibrillation

Gordon A Begg, Peter Swoboda, Eduard Shantsila, Gregory Lip
2020-05-27

Blood pressure targets in atrial fibrillation

Eduard Shantsila, Gregory Lip, Alena Shantsila
2020-09-10

Spironolactone in Atrial Fibrillation With Preserved Cardiac Fraction: The IMPRESS-AF Trial

Eduard Shantsila, Gregory Lip, James Fisher, Farhan Shahid
2020-11-07

Observations on clot properties in atrial fibrillation: Relation to renal function and choice of anticoagulant

Eduard Shantsila, Gregory Lip
2019-05-01

Microparticles and cardiovascular diseases

Christos Voukalis, Eduard Shantsila, Gregory Lip
2019-11-06

Guideline-Adherent Treatment for Stroke and Death in Atrial Fibrillation Patients From UK and Japanese AF Registries

Michał Mazurek, Eduard Shantsila, Deirdre A Lane, Gregory Lip, Hisashi Ogawa, Masaharu Akao
2018-01

7 Monocyte subpopulations in patients following st-elevation myocardial infarction: implications for post-infarction left ventricular remodelling and clinical outcomes

Eduard Shantsila
2018-06

92 High heart rate predicts cardiac fibrosis in patients with atrial fibrillation and preserved left ventricular function

Gregory Lip, Eduard Shantsila, Farhan Shahid
2018-06

97 Total monocyte count as predictor of exercise capacity in patients with permanent atrial fibrillation and preserved left ventricular function – the west birmingham AF project

Gregory Lip, Eduard Shantsila, Farhan Shahid
2018-02-09

Impact of Mon2 monocyte-platelet aggregates in humancoronary artery disease.

Gregory Lip, Eduard Shantsila, Chetan Varma
2018-02-01

Role of Monocytes in Heart Failure and Atrial Fibrillation.

Gregory Lip, Eduard Shantsila, Farhan Shahid
2018-04-12

Nitrite circumvents platelet resistance to nitric oxide in patients with heart failure preserved ejection fraction and chronic atrial fibrillation.

Janet M Lord, Steve P. Watson, Paulus Kirchhof, Martin Feelisch, Gregory Lip, Eduard Shantsila
2018-05-01

Predictors of diastolic dysfunction in ethnic groups: observations from the Hypertensive Cohort of The Ethnic-Echocardiographic Heart of England Screening Study (E-ECHOES).

Gregory Lip, Eduard Shantsila, Alena Shantsila
2018-07-18

Prognostic implication of monocytes in atrial fibrillation: The West Birmingham Atrial Fibrillation Project

Farhan Shahid, Eduard Shantsila, Gregory Lip
2018-10-01

Heart Failure and Stroke

Eduard Shantsila, Gregory Lip
2018-05-30

Non-Vitamin K Antagonist Oral Anticoagulants: A Concise Guide

Eduard Shantsila, Gregory Lip
2017-08-01

Guideline-Adherent Antithrombotic Treatment Improves Outcomes in Patients With Atrial Fibrillation: Insights From the Community-Based Darlington Atrial Fibrillation Registry

Michał Mazurek, Marco Proietti, Gregory Lip, Eduard Shantsila, Deirdre A Lane
2017-07-01

Renin-angiotensin blockade in atrial fibrillation: where are we now?

Eduard Shantsila, Gregory Lip
2017-09-11

Atrial Fibrillation and Hypertension.

Mikhail S. Dzeshka, Gregory Lip, Eduard Shantsila, Alena Shantsila
2017-03-16

Clinical Features and Prognosis in Patients with Atrial Fibrillation and Prior Stroke: Comparing the Fushimi and Darlington AF Registries

Gregory Lip, Eduard Shantsila, Deirdre A Lane, Alena Shantsila, Hisashi Ogawa, Keitaro Senoo, Masaharu Akao
2017-06-14

Predictors of 5-year outcomes in malignant phase hypertension: the West Birmingham Malignant Hypertension Registry

Gregory Lip, Eduard Shantsila, Alena Shantsila, D Gareth Beevers
2017-09-01

Is echocardiography valid and reproducible in patients with atrial fibrillation? A systematic review

Dipak Kotecha, Mohamed Mohamed, Eduard Shantsila
2017-07-05

Secondary Versus Primary Stroke Prevention in Atrial Fibrillation: Insights From the Darlington Atrial Fibrillation Registry

Michał Mazurek, Marco Proietti, Gregory Lip, Eduard Shantsila, Deirdre A Lane
2016-12-22

What do the guidelines suggest for non-vitamin K antagonist oral anticoagulant use for stroke prevention in atrial fibrillation?

Gregory Lip, Eduard Shantsila, Farhan Shahid
2016-07-14

Role and analysis of monocyte subsets in cardiovascular disease. Joint consensus document of the European Society of Cardiology (ESC) Working Groups "Atherosclerosis & Vascular Biology" and "Thrombosis".

Christian Weber, Claudia Monaco, Johann Wojta, Imo Hoefer, Gregory Lip, Agneta Siegbahn, Giuseppina Caligiuri, Sabine Steffens, Karlheinz Peter, Eduard Shantsila, Tomasz Guzik
2016-02-01

Emerging Tools for Stroke Prevention in Atrial Fibrillation

Gregory Lip, Eduard Shantsila, Christos Voukalis
2016-09-15

Antiplatelet versus anticoagulation treatment for patients with heart failure in sinus rhythm

Eduard Shantsila, Gregory Lip
2016-08-23

Effects of non-vitamin K antagonist oral anticoagulants on fibrin clot and whole blood clot formation, integrity and thrombolysis in patients with atrial fibrillation

Gregory Lip, Eduard Shantsila, Andrew D Blann, Qinmei Xiong
2016-10-05

IMproved exercise tolerance in patients with PReserved Ejection fraction by Spironolactone on myocardial fibrosiS in Atrial Fibrillation rationale and design of the IMPRESS-AF randomised controlled trial

Paulus Kirchhof, Gregory Lip, Melanie Calvert, Eduard Shantsila
2016-11-10

Premature Cardiac Aging in South Asian Compared to Afro-Caribbean Subjects in a Community-Based Screening Study

Gregory Lip, Eduard Shantsila, Alena Shantsila
2016-12-20

Recent advances in the understanding and management of atrial fibrillation: a focus on stroke prevention

Gregory Lip, Eduard Shantsila, Farhan Shahid
2016-01-19

Endothelial Progenitors and Blood Microparticles: Are They Relevant to Heart Failure With Preserved Ejection Fraction?

Gregory Lip, Eduard Shantsila

Human - wd:Q43267124

Welcome to Inventaire

the library of your friends and communities

learn more